Is AbbVie Stock a Buy Now?
AbbVie (NYSE: ABBV) closed out a pivotal 2024 with an excellent fourth-quarter earnings report. For the period ended Dec. 31, ...
JD Supra23h
Mintz IRA Update — The IRA in 2025: The Future of Medicare Part D
Last year was a pivotal year for the pharmaceutical industry. Under the IRA’s Medicare Drug Price Negotiation Program (the ...